(Q34339662)

English

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

object named as

Elías Campo

14

0 references

Randy D Gascoyne

12

object named as

Randy D Gascoyne

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Andreas Rosenwald

10

object named as

Andreas Rosenwald

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

13

object named as

Elaine S Jaffe

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

23

object named as

Lisa M Rimsza

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Rita M. Braziel

16

object named as

Rita M Braziel

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Anamarija M Perry

7

object named as

Anamarija M Perry

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Christian Steidl

21

object named as

Christian Steidl

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Samantha Kendrick

1

object named as

Samantha L Kendrick

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Lucas Redd

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Andrea Muranyi

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Leigh A Henricksen

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Stacey Stanislaw

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Lynette M Smith

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Kai Fu

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dennis D Weisenburger

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

German Ott

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

James R Cook

17

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Raymond R Tubbs

18

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Louis M Staudt

19

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Wing Chung Chan

20

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Thomas M Grogan

22

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

26 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Human Pathology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2144-2153

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

BCL2 mutations in diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Automated brightfield break-apart in situ hybridization (ba-ISH) application: ALK and MALT1 genes as models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Bcl2's flexible loop domain regulates p53 binding and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

Bcl-2 phosphorylation required for anti-apoptosis function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

6 July 2018

The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

27 October 2018

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

27 October 2018

Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4197184

27 October 2018

Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25090918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25090918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/25090918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/25090918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/25090918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/25090918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.HUMPATH.2014.06.005

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34339662&oldid=1858063421"